Brokerages Set Surgery Partners, Inc. (NASDAQ:SGRY) Price Target at $31.07


Share on StockTwits

Shares of Surgery Partners, Inc. (NASDAQ:SGRY) have received a consensus recommendation of “Buy” from the nine analysts that are currently covering the stock, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $31.07.

A number of equities research analysts have recently issued reports on the company. Royal Bank of Canada boosted their target price on Surgery Partners from $36.00 to $54.00 and gave the stock an “outperform” rating in a research report on Thursday, March 11th. Zacks Investment Research raised Surgery Partners from a “sell” rating to a “hold” rating in a research report on Friday, February 19th.

Shares of SGRY traded down $1.35 during midday trading on Thursday, reaching $48.78. The stock had a trading volume of 7,101 shares, compared to its average volume of 451,710. Surgery Partners has a 52 week low of $8.57 and a 52 week high of $52.42. The company has a debt-to-equity ratio of 3.45, a current ratio of 1.51 and a quick ratio of 1.43. The firm’s 50 day moving average price is $44.52 and its 200-day moving average price is $33.64. The company has a market capitalization of $2.92 billion, a P/E ratio of -13.73 and a beta of 3.18.

Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Tuesday, March 9th. The company reported $0.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.02 by $0.07. The company had revenue of $548.30 million for the quarter. Surgery Partners had a negative return on equity of 4.73% and a negative net margin of 7.64%. On average, equities analysts forecast that Surgery Partners will post -1.45 earnings per share for the current year.

Several large investors have recently bought and sold shares of the company. Dorsey Wright & Associates raised its stake in shares of Surgery Partners by 134.7% in the 1st quarter. Dorsey Wright & Associates now owns 1,652 shares of the company’s stock valued at $73,000 after purchasing an additional 948 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Surgery Partners by 62.1% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,110 shares of the company’s stock valued at $119,000 after acquiring an additional 1,575 shares during the last quarter. Panagora Asset Management Inc. acquired a new stake in shares of Surgery Partners in the fourth quarter valued at about $208,000. Price T Rowe Associates Inc. MD acquired a new stake in shares of Surgery Partners in the fourth quarter valued at about $215,000. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of Surgery Partners in the fourth quarter valued at about $300,000. Institutional investors and hedge funds own 94.10% of the company’s stock.

About Surgery Partners

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through Surgical Facility Services and Ancillary Services segments. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

Further Reading: Street Name

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.